Sign Out
Avodart treats and prevents progression of benign prostatic hyperplasia (BPH) through alleviating symptoms, reducing prostate size (volume), improving urinary flow rate and reducing the risk of acute urinary retention (AUR) and the need for BPH-related surgery.
Avodart in combination with alpha-blocker tamsulosin, is indicated for the treatment of moderate to severe symptomatic benign prostatic hyperplasia (BPH) in men with enlarged prostate.
